News

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced positive ...
It might be of some concern to shareholders to see the Landmark Bancorp, Inc. ( NASDAQ:LARK ) share price down 18% ...